A Phase 2, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Dose-Comparison Trial of OPC-6535 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Trial Profile

A Phase 2, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Dose-Comparison Trial of OPC-6535 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Tetomilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 09 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 15 May 2013 Planned end date changed from 1 May 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 15 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top